Emtricitabine tenofovir alafenamide clinical trials
How each study uses emtricitabine tenofovir alafenamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the emtricitabine tenofovir alafenamide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2020 (4)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 14
Gilead Sciences (3) · National University Hospital, Singapore (1) · University of Washington (1) · University of Miami (1) · Vivent Health (1) · Janssen Research & Development, LLC (1) · MRC/UVRI and LSHTM Uganda Research Unit (1) · University Health Network, Toronto (1)
Often tested with
Tested in the same studies.
Emtricitabine (7) · Darunavir (5) · Cobicistat (5) · Tenofovir alafenamide (5) · Tenofovir (3) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2) · Atazanavir (2) · Elvitegravir (2)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test emtricitabine tenofovir alafenamide.
Studies
Open first, then newest update. How each study uses emtricitabine tenofovir alafenamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 20
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV TreatmentsRecruitingPhase 4Gilead SciencesNCT06337032Written as F/TAF (High Dose Tablet)How we know
- Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.RecruitingPhase 3ANRS, Emerging Infectious DiseasesNCT05813964Written as TAF/FTC 25mg/200mg fixed-dose combination tabletsHow we know
- Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV InfectionActive, not recruitingPhase 3Gilead SciencesNCT04925752Written as F/TAF (for US participants only)How we know
- Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore StudyActive, not recruitingPhase 1National University Hospital, SingaporeNCT07210528Written as Descovy® (TAF/FTC)How we know
- The Women TAF-FTC Benchmark StudyCompletedPhase 2/3University of WashingtonNCT05140954Written as co-formulated 25mg TAF/ 200mg FTCHow we know
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVActive, not recruitingPhase 2/3Gilead SciencesNCT02016924Written as F/TAF TOSHow we know
- PrEP at a Syringe Services ProgramCompletedPhase 4University of MiamiNCT04782180Written as Descovy 200Mg 25Mg TabletHow we know
- Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"CompletedPhase 4Vivent HealthNCT05528653Written as DescovyHow we know
- TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)TerminatedPhase 3Hospital Italiano de Buenos AiresNCT04405271Written as Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral TabletHow we know
- A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate AgentsCompletedPhase 1Janssen Research & Development, LLCNCT04661397Written as Emtricitabine/Tenofovir AlafenamideHow we know
- A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEPCompletedPhase 2MRC/UVRI and LSHTM Uganda Research UnitNCT04066881Written as Experimental PrEP:TAF/FTC once daily (weeks 0-26)How we know
- Bone Health in Aging HIV Infected WomenCompletedPhase 4University Health Network, TorontoNCT02815566Written as tenofovir-alafenamide-emtricitabineHow we know
- Project Engage: Oral PrEP AcceptabilityCompletedPhase 2Eastern Virginia Medical SchoolNCT05458765Written as emtricitabine/tenofovir alafenamideHow we know
- Rapid HIV Treatment Initiation, Access and Engagement in CareCompletedNot applicableJohns Hopkins UniversityNCT03512964Written as Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet [DESCOVY]How we know
- Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral DrugsCompletedEarly Phase 1Rhonda BrandNCT04302896Written as emtricitabine/tenofovir alafenamide oral tablet 200mg/25mgHow we know
- Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir AlafenamideCompletedPhase 4Philadelphia FightNCT03350672Written as FTC/TAFHow we know
- A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat When Administered as a Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared to the Co-administration of the Separate AgentsTerminatedPhase 1Janssen Pharmaceutica N.V., BelgiumNCT04236453Written as Emtricitabine/Tenofovir AlafenamideHow we know
- RIFT: Effect of Rifampicin on Plasma PK of FTC, TAF and Intracellular TFV-DP & FTC-TPCompletedPhase 1St. Stephens Clinical ResearchNCT03186482Written as Descovy® (TAF/FTC)How we know
- Emtricitabine/Tenofovir Alafenamide as Salvage ARTTerminatedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT02556333Written as FTC/TAFHow we know
- Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose CombinationCompletedPhase 1Janssen Sciences Ireland UCNCT02475135Written as Emtricitabine/Tenofovir alafenamide (FTC/TAF)How we know
Given beside what is tested · 5 — emtricitabine tenofovir alafenamide is usual care or a partner of the new treatment
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)RecruitingPhase 2ViiV HealthcareNCT07202546Written as Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tabletsHow we know
- Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their InfantsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT03048422Written as Emtricitabine/tenofovir alafenamideHow we know
- A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive AdultsTerminatedPhase 2ViiV HealthcareNCT04493216Written as FTC/TAFHow we know
- Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected IndividualsCompletedPhase 2Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaNCT04097925Written as DescovyHow we know
- Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected IndividualsCompletedPhase 3Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaNCT04079452Written as DescovyHow we know
As the comparator · 3 — what is tested is compared with emtricitabine tenofovir alafenamide
- Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Are at High Risk for HIV-1 Infection (MK-8591-024)TerminatedPhase 3Merck Sharp & Dohme LLCNCT04652700Written as FTC/TAFHow we know
- Dual Therapy With Boosted Darunavir + DolutegravirCompletedPhase 3Technical University of MunichNCT02486133Written as DescovyHow we know
- Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).Status unknownPhase 4ADRIANO LAZZARIN, MDNCT04225325Written as DESCOVY+DOLUTEGRAVIRHow we know
Codes
What other systems call emtricitabine tenofovir alafenamide · ClinicalTrials.gg INT000591
- MeSH (NLM) C000613801emtricitabine tenofovir alafenamideOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000613801 | emtricitabine tenofovir alafenamide | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.